Your browser doesn't support javascript.
loading
Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo.
Zhang, Yi-Xiang; Sicinska, Ewa; Czaplinski, Jeffrey T; Remillard, Stephen P; Moss, Samuel; Wang, Yuchuan; Brain, Christopher; Loo, Alice; Snyder, Eric L; Demetri, George D; Kim, Sunkyu; Kung, Andrew L; Wagner, Andrew J.
  • Zhang YX; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sicinska E; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Czaplinski JT; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Remillard SP; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Moss S; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wang Y; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Brain C; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.
  • Loo A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.
  • Snyder EL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Demetri GD; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kim S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.
  • Kung AL; Department of Pediatrics, Columbia University Medical Center, New York, New York.
  • Wagner AJ; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Andrew_Wagner@dfci.harvard.edu.
Mol Cancer Ther ; 13(9): 2184-93, 2014 Sep.
Article en En | MEDLINE | ID: mdl-25028469
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinasa 4 Dependiente de la Ciclina / Quinasa 6 Dependiente de la Ciclina / Liposarcoma Límite: Animals / Female / Humans / Male Idioma: En Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinasa 4 Dependiente de la Ciclina / Quinasa 6 Dependiente de la Ciclina / Liposarcoma Límite: Animals / Female / Humans / Male Idioma: En Año: 2014 Tipo del documento: Article